PROXIMAGEN LLC – Trademark Portfolio
Entity Type: 16
PROXIMAGEN LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NAYZILAM and PROXIMAGEN. The owner is based in PLYMOUTH, MN.
505 NORTH HIGHWAY 169
PLYMOUTH, MN 55441
Showing of trademarks Trademarks
Trademark Classifications
PROXIMAGEN LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does PROXIMAGEN LLC have?
PROXIMAGEN LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does PROXIMAGEN LLC file in?
PROXIMAGEN LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are PROXIMAGEN LLC's most well-known trademarks?
PROXIMAGEN LLC's registered trademark portfolio includes well-known marks such as NAYZILAM and PROXIMAGEN. These are among 2 currently registered trademarks in the portfolio.
What is PROXIMAGEN LLC's trademark registration success rate?
PROXIMAGEN LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.